Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Merck
Colorcon
Harvard Business School
Moodys
Boehringer Ingelheim
Mallinckrodt

Last Updated: December 7, 2019

DrugPatentWatch Database Preview

Drugs with Dosage: SUSPENSION

See Plans and Pricing

« Back to Dashboard

Drugs with Dosage: SUSPENSION

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration Dosage
Novel Labs Inc NITROFURANTOIN nitrofurantoin SUSPENSION;ORAL 201693-001 Sep 8, 2014 AB RX No No   Start Trial   Start Trial   Start Trial SUSPENSION;ORAL
Italfarmaco Spa TIGLUTIK KIT riluzole SUSPENSION;ORAL 209080-001 Sep 5, 2018 RX Yes Yes   Start Trial   Start Trial Y   Start Trial SUSPENSION;ORAL
Allergan FML-S fluorometholone; sulfacetamide sodium SUSPENSION/DROPS;OPHTHALMIC 019525-001 Sep 29, 1989 DISCN No No   Start Trial   Start Trial   Start Trial SUSPENSION/DROPS;OPHTHALMIC
Lilly ILOSONE SULFA erythromycin estolate; sulfisoxazole acetyl SUSPENSION;ORAL 050599-001 Sep 29, 1989 DISCN No No   Start Trial   Start Trial   Start Trial SUSPENSION;ORAL
Monarch Pharms PEDIOTIC hydrocortisone; neomycin sulfate; polymyxin b sulfate SUSPENSION/DROPS;OTIC 062822-001 Sep 29, 1987 DISCN No No   Start Trial   Start Trial   Start Trial SUSPENSION/DROPS;OTIC
Insmed Inc ARIKAYCE KIT amikacin sulfate SUSPENSION, LIPOSOMAL;INHALATION 207356-001 Sep 28, 2018 RX Yes Yes   Start Trial   Start Trial   Start Trial SUSPENSION, LIPOSOMAL;INHALATION
Insmed Inc ARIKAYCE KIT amikacin sulfate SUSPENSION, LIPOSOMAL;INHALATION 207356-001 Sep 28, 2018 RX Yes Yes   Start Trial   Start Trial   Start Trial SUSPENSION, LIPOSOMAL;INHALATION
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration >Dosage

Subscribe to access the full database, or Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Harvard Business School
Dow
Medtronic
McKesson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2019 - 2020
 NCE-1 Patent Challenge Dates 2019 - 2020
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.

Links

Follow DrugPatentWatch:

DrugPatentWatch reviews